vancomycin has been researched along with Febrile Neutropenia in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (46.67) | 24.3611 |
| 2020's | 16 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, U; Ito, S; Mizuno, T; Schechter, T; Shimamoto, Y; Verstegen, RHJ | 1 |
| Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC | 1 |
| Andrick, B; Leri, F; Okubo, L; Rampulla, R | 1 |
| Amini, S; Ekhtiari Kolour, SR; Hadjibabaie, M; Kargar, M; Mohammadi, M; Sadeghi, K; Shahrami, B; Taghvaye Masoumi, H; Vaezi, M | 1 |
| Amano, E; Hashimoto, T; Hiramatsu, K; Itoh, H; Ono, H; Tanaka, R; Tatsuta, R | 1 |
| Bouscary, D; Canouï, E; Charlier, C; Contejean, A; Fantin, B; Garcia-Vidal, C; Kernéis, S; Maillard, A; Parize, P | 1 |
| Gandolpho, LS; Guaraná, M; Molla, VC; Nouér, SA; Nucci, M; Pereira, AD; Ramos, JF; Rodrigues, CA; Seiwald, MCN | 1 |
| Guarana, M; Nouér, SA; Nucci, M | 1 |
| Karandikar, MV; Milliren, CE; Peiris, P; Place, AE; Sandora, TJ; Sharma, T; Zaboulian, R | 1 |
| Faine, BA; Jansma, B; Negaard, B; Talan, DA; Vakkalanka, P | 1 |
| Cao, P; Gao, LL; Li, SC; Nie, YM; Wang, J; Wang, Y; Wu, M; Xu, H; Ye, Q | 1 |
| Courter, J; Dahale, D; Danziger-Isakov, L; Demmel, K; Geller, J; Goldstein, SL; Haslam, DB; O'Brien, M; Young, J | 1 |
| Harada, S; Kanemura, N; Kitagawa, J; Matsumoto, T; Nakamura, H; Nakamura, N; Niwa, T; Ohata, K; Shimizu, M; Suzuki, A; Takahashi-Yamauchi, T | 1 |
| Akalin, H; Ali, R; Bulbul, EN; Kazak, E; Kirkizlar, O; Kirkizlar, TA; Ozakin, C; Ozboz, ES; Ozkalemkas, F; Ozkocaman, V | 1 |
| Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K | 1 |
| Damon, L; DeVoe, C; Doernberg, SB; Dzundza, JH; Graff, LR; Griffith, LM; Gu, TM; Hampton, SR; Hilts-Horeczko, A; Macapinlac, BAC; Olin, R; Rodriguez-Monguio, R; Shenoy, S; Strnad, L; Trinh, TD; Wang, L; Yang, K | 1 |
| Bowen, AC; Ferguson, P; Foley, DA; Hamilton, K; Kotecha, RS; Ruhayel, SD; Yeoh, DK | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| Leong, D; Wu, PE | 1 |
| Bergstrom, C; Gupta, A; Nagalla, S | 1 |
| Hirai, K; Ishii, H; Itoh, K; Kimura, M; Nakatani, E; Sugiyama, K | 1 |
| Arda, B; Avci, M; Cag, Y; Demirdal, T; Dizbay, M; Erdem, HA; Kahraman, H; Kandemir, O; Karasahin, O; Kaya, S; Kurtaran, B; Kutlu, M; Oruc, E; Oztoprak, N; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Tunccan, OG; Ulug, M; Ulusoy, S; Yamazhan, T; Yetkin, F | 1 |
| Bar, N; Foss, F; Gowda, L; Isufi, I; Malinis, M; McManus, D; Perreault, S; Seropian, S; Topal, JE | 1 |
| Gea-Banacloche, J | 1 |
| Hiramatsu, K; Itoh, H; Kadota, J; Kohno, K; Morinaga, Y; Ogata, M; Sato, Y; Suzuki, Y; Takano, K; Tokimatsu, I | 1 |
| Hirai, K; Hirano, K; Ihara, S; Ikegaya, K; Itoh, K; Kinae, A; Suzuki, M | 1 |
| Demir, AM; Kuloğlu, F; Ümit, EG | 1 |
| Al-Nahedh, M; Knoebel, RW; Parsad, S; Pettit, NN; Pisano, J; Vicente, M | 1 |
| André, N; Boulamery, A; Coze, C; Dupouey, J; Galambrun, C; Guilhaumou, R; Marsot, A; Simon, N | 1 |
| Hirai, K; Inoue, K; Ishii, H; Itoh, K; Kadoiri, T; Shimomura, T; Shimoshikiryo, T; Tsuji, D | 1 |
4 review(s) available for vancomycin and Febrile Neutropenia
| Article | Year |
|---|---|
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans; Vancomycin | 2023 |
Shock and Early Death in Hematologic Patients with Febrile Neutropenia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Febrile Neutropenia; Fever; Humans; Retrospective Studies; Shock; Vancomycin | 2019 |
Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Febrile Neutropenia; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Microbial Sensitivity Tests; Practice Guidelines as Topic; Prospective Studies; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2021 |
Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.
Topics: Anti-Bacterial Agents; Antifungal Agents; Evidence-Based Medicine; Febrile Neutropenia; Hematologic Neoplasms; Humans; Infections; Mycoses; Risk Factors; Vancomycin | 2013 |
1 trial(s) available for vancomycin and Febrile Neutropenia
| Article | Year |
|---|---|
A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy.
Topics: Adult; Aged; Drug Monitoring; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; ROC Curve; Treatment Outcome; Vancomycin | 2015 |
25 other study(ies) available for vancomycin and Febrile Neutropenia
| Article | Year |
|---|---|
Population pharmacokinetics of vancomycin in paediatric patients with febrile neutropenia and augmented renal clearance: development of new dosing recommendations.
Topics: Anti-Bacterial Agents; Child; Febrile Neutropenia; Glomerular Filtration Rate; Humans; Infant; Monte Carlo Method; Vancomycin | 2021 |
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole | 2021 |
Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Febrile Neutropenia; Fever; Humans; Retrospective Studies; Vancomycin | 2022 |
Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
Topics: Anti-Bacterial Agents; Febrile Neutropenia; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Iran; Neoplasms; Referral and Consultation; Vancomycin | 2023 |
Association of Vancomycin Trough Concentration and Clearance With Febrile Neutropenia in Pediatric Patients.
Topics: Adult; Anti-Bacterial Agents; Child; Febrile Neutropenia; Humans; Pediatrics; Retrospective Studies; Vancomycin | 2022 |
Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Febrile Neutropenia; Fever; Humans; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2023 |
Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Male; Neoplasms; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2020 |
Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cohort Studies; Emergency Service, Hospital; Febrile Neutropenia; Female; Guideline Adherence; Hospitalization; Humans; Male; Middle Aged; Neoplasms; Patient Discharge; Retrospective Studies; Risk Factors; Tertiary Care Centers; Vancomycin | 2020 |
Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Child, Preschool; Computer Simulation; Drug Administration Schedule; Drug Elimination Routes; Febrile Neutropenia; Female; Glomerular Filtration Rate; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Treatment Outcome; Vancomycin | 2020 |
Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications.
Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Databases, Factual; Febrile Neutropenia; Female; Humans; Infant; Male; Neoplasms; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Teicoplanin; Vancomycin; Young Adult | 2020 |
Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Enterococcus faecium; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sex Factors; Soft Tissue Infections; Turkey; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2020 |
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.
Topics: Adult; Algorithms; Clostridioides difficile; Febrile Neutropenia; Humans; Interrupted Time Series Analysis; Meropenem; Vancomycin | 2021 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 2018 |
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply.
Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 2018 |
Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brain Injuries; Drug Monitoring; Febrile Neutropenia; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasms; Nomograms; Retrospective Studies; Vancomycin | 2018 |
Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Non-Randomized Controlled Trials as Topic; Retrospective Studies; Teicoplanin; Treatment Outcome; Turkey; Vancomycin; Young Adult | 2019 |
The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).
Topics: Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Febrile Neutropenia; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medication Therapy Management; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nose; Retrospective Studies; Staphylococcal Infections; Time Factors; Vancomycin; Young Adult | 2019 |
Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Asian People; Bayes Theorem; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Febrile Neutropenia; Female; Glomerular Filtration Rate; Humans; Infant; Logistic Models; Male; Multivariate Analysis; Risk Factors; Vancomycin | 2016 |
Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies.
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Febrile Neutropenia; Female; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Length of Stay; Leukemia; Logistic Models; Male; Middle Aged; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2017 |
Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Pathways; Empirical Research; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Neoplasms; Practice Guidelines as Topic; Retrospective Studies; Vancomycin | 2017 |
Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
Topics: Anti-Bacterial Agents; Child; Cyclosporine; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Models, Biological; Neoplasms; Retrospective Studies; Vancomycin | 2016 |
Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Critical Illness; Febrile Neutropenia; Female; Humans; Kidney; Kidney Function Tests; Logistic Models; Male; Middle Aged; Risk Factors; Vancomycin | 2016 |